Capital Rx

About

Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.

New York,New York,United States
251 - 500
https://cap-rx.com

Highlights

Details

Last Funding Type: Series C
Last Funding Money Raised: $106M
Industries: Health Care,Medical,Pharmaceutical
Founded date: Dec 1, 2017
Number Of Employee: 251 - 500
Operating Status: Active
Legal Name: Capital Rx, Inc.

Capital Rx is a health technology company that engages in managing pharmacy benefit plans. The company is redefining the way prescriptions are priced and administered in the U.S. Through its Clearinghouse Model, it unlocks the pharmacy supply chain and reduces prescription costs for employer groups. By establishing a competitive marketplace for drug pricing, Capital Rx focuses its resources on deploying actionable strategies that improve plan performance and patient outcomes.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$202.96M

Capital Rx has raised a total of $202.96M in funding over 2 rounds. Their latest funding was raised on Jun 13, 2022 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 13, 2022	Series C	$106M	4	B Capital Group	—	Detail
Feb 2, 2021	Series B	$50M	4	Transformation Capital	—	Detail
Jan 5, 2021	Series Unknown	$31.96M	—	—	—	Detail
Jul 3, 2019	Series A	$12M	2	Edison Partners	—	Detail
Mar 15, 2018	Seed	$3M	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

6

1

Capital Rx has made 6 investments. Their most recent investment was on Sep 17, 2021, when Authena raised $2.40M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Sep 17, 2021 Authena	Seed	$2.40M	Blockchain	—
Jul 28, 2021 AURA Network Systems	Series A	$30.90M	Air Transportation	—
Mar 1, 2021 Sojo	Seed	$5M	Hospitality	Yes
Nov 1, 2020 Chintai	Pre-seed	$200K	Blockchain	—
Feb 1, 2020 GX Blocks Energy	Angel	—	Blockchain	—

Investors

Number of Lead Investors

Number of Investors

3

7

Capital Rx is funded by 7 investors. B Capital Group and General Catalyst are the most recent investors.

Investor Name	Lead Investor	Funding Round
B Capital Group	Yes	Series C
General Catalyst	—	Series C
Edison Partners	—	Series C
Transformation Capital	—	Series C
Alumni Ventures	—	Series B
Castor Ventures	—	Series B
Emerald Development Managers	—	Series A